Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 19/20 | 0.56 |
| ▸ | CTSD | P07339 | 14/20 | 0.56 |
| ▸ | BACE2 | Q9Y5Z0 | 4/20 | 0.56 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL924766 | 0.89 | BACE1 (0.57) | BACE1CTSDBACE2 | |
| SCHEMBL924767 | 0.89 | BACE1 (0.57) | BACE1CTSDBACE2 | |
| SCHEMBL924428 | 0.88 | BACE1 (0.55) | BACE1CTSDBACE2 | |
| SCHEMBL924430 | 0.88 | BACE1 (0.55) | BACE1CTSDBACE2 | |
| SCHEMBL4045626 | 0.88 | BACE1 (0.56) | BACE1CTSDBACE2 | |
| Hydrochloric Acid SCHEMBL925290 | 0.87 | BACE1 (0.60) | BACE1CTSDBACE2 | |
| Hydrochloric Acid SCHEMBL924364 | 0.87 | BACE1 (0.60) | BACE1CTSDBACE2 | |
| Hydrochloric Acid SCHEMBL924365 | 0.87 | BACE1 (0.60) | BACE1CTSDBACE2 | |
| Hydrochloric Acid SCHEMBL925288 | 0.87 | BACE1 (0.60) | BACE1CTSDBACE2 | |
| SCHEMBL4048800 | 0.83 | BACE1 (0.44) | BACE1CTSDBACE2F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612054-B2 | Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof | NOVARTIS AG (CH) | 2009-11-03 | — | — | US | disclosed |
| US-20070111991-A1 | Novel dibenzo [b, f] oxepine-10-carboxamides and pharmaceutical uses thereof | NOVARTIS AG (CH) | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070111991-A1 | Novel dibenzo [b, f] oxepine-10-carboxamides and pharmaceutical uses thereof | APP, BACE1, BCHE | BACE1 2/4885CTSD 1669/4885BACE2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.